Full-Time

Traksys Software Developer

Posted on 12/21/2024

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Mid, Senior

Remote in USA

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
JavaScript
SQL
C#
Selenium
Requirements
  • BS in Computer Science or Engineering (Computer, Electrical, Mechanical)
  • 2+ years’ experience configuring and developing Parsec TrakSYS applications
  • 5+ years experience programming in C#, .NET and javascript
  • Experience with SQL
  • Basic knowledge of API data structures and communications
  • Familiarity with working in a FDA GMP manufacturing environment
  • Basic knowledge of FDA CFR part 11 compliance
Responsibilities
  • Write highly efficient and maintainable production-level code in C#.
  • Collaborate with cross-functional teams to develop, test, and deploy software solutions that meet business requirements.
  • Ensure code quality through best practices, including code reviews, testing using Selenium.
  • Optimize application performance, scalability, and reliability.
  • Work closely with product managers, designers, scientific subject matter experts and other developers to deliver high-quality software products.
  • Participate in architectural discussions and contribute to the overall Traksys implementation at the company.
  • Work with the middleware development team on the product modules integration.

Orca Bio operates in the biotechnology field, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently lack effective treatments.

Company Stage

Series D

Total Funding

$186.8M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

12%

1 year growth

16%

2 year growth

42%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca-T shows promising relapse-free survival rates in hematologic malignancies.
  • The FDA's fast-tracking of cell therapy approvals supports Orca Bio's innovative treatments.
  • Orca Bio's therapies align with the trend towards value-based healthcare.

What critics are saying

  • Competition from companies like BlueRock Therapeutics challenges Orca Bio's market position.
  • Rapid advancements by Aspen Neuroscience pose a competitive threat to Orca Bio.
  • Emerging autologous iPSC-derived therapies could overshadow Orca Bio's offerings.

What makes Orca Bio unique

  • Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
  • The company uses single-cell precision to create uniquely-defined cell therapy products.
  • Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Help us improve and share your feedback! Did you find this helpful?